Skip to content
Screener

Arrowhead Research ARWR Total Operating Expenses

Total Operating Expenses at other companies

Assembly Biosciences logo
Assembly BiosciencesASMB
$19.58M+1.2%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$10.22M-62.8%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$138.95M+9.6%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$125.28M+2.4%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$218.78M+64.8%
Precigen logo
PrecigenPGEN
$29.25M+22.2%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025Six Months Ended March 31, 2026Six Months Ended March 31, 2025
Operating expenses:
Research and development173,253133,102350,456270,104
Selling, general and administrative41,74428,40587,76555,315
Total operating expenses214,997161,507438,221325,419
Operating (loss) income(141,260)381,202(100,451)219,790
Other income (expense):
Interest income16,8699,61526,56017,217
Interest expense(23,846)(21,639)(46,351)(43,285)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's total operating expenses?
Arrowhead Research (ARWR) reported total operating expenses of $215M in Q1 2026.
How has Arrowhead Research's total operating expenses changed year-over-year?
Arrowhead Research's total operating expenses increased by 33.1% year-over-year, from $161.51M to $215M.
What is the long-term trend for Arrowhead Research's total operating expenses?
Over 4 years (2021 to 2025), Arrowhead Research's total operating expenses has grown at a 26.3% compound annual growth rate (CAGR), from $287.33M to $731.1M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Ask your AI about Arrowhead Research's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude